| Stage | SNX | % of rev | SCSC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $21.6B | 100.00% | $953M | 100.00% | SNX ×22.62 |
| Gross profit | $1.4B | 6.61% | $120M | 12.57% | SCSC +6.0pp |
| Operating income | $643M | 2.98% | $32M | 3.33% | SCSC +0.3pp |
| Pre-tax income | $555M | 2.58% | $33M | 3.49% | SCSC +0.9pp |
| Net income | $416M | 1.93% | $26M | 2.69% | SCSC +0.8pp |
| Stage | SNX | SCSC | Gap · A − B |
|---|---|---|---|
| Revenue | $21.6B100.00% | $953M100.00% | SNX ×22.62 |
| Gross profit | 6.61%$1.4B | 12.57%$120M | SCSC +6.0pp |
| Operating income | 2.98%$643M | 3.33%$32M | SCSC +0.3pp |
| Pre-tax income | 2.58%$555M | 3.49%$33M | SCSC +0.9pp |
| Net income |
| 1.93%$416M |
| 2.69%$26M |
| SCSC +0.8pp |
No shared counterparties.